Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models

Sengoku, Takanori; Sakuma, Shozo; Satoh, Shinya; Kishi, Shinichi; Ogawa, Toshikazu; Ohkubo, Y.; Mutoh, Seitaro

doi:10.1046/j.1365-2222.2003.01698.x

Cited by 34 publications

(30 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Induction of Late Phase Reaction in the Allergic Conjunctivitis Model Allergic conjunctivitis was induced using the method of Sengoku et al, 11) with some modification. OVA solution (40 mg/ml dissolved in saline) was emulsified with an equal volume of FCA.…”

Section: Reagentsmentioning

confidence: 99%

See 1 more Smart Citation

Inhibitory Effects of Cyclosporine A Eye Drops on Symptoms in Late Phase and Delayed-Type Reactions in Allergic Conjunctivitis Models

Shii

Nakagawa

Yoshimi

et al. 2010

Biological & Pharmaceutical Bulletin

View full text Add to dashboard Cite

Cyclosporine A (CyA) is a cyclic polypeptide calcineurin inhibitor that was first purified in the 1970s by Novartis Pharma (formerly Sandoz Pharma, Switzerland) from cultures of the fungus Tolypocladium inflatum. It has long been a trusted agent for suppressing not only graft rejection after transplantation, but also immune reaction disorders often observed in autoimmune diseases. The therapeutic effects of CyA eye drops in the treatment of vernal keratoconjunctivitis (VKC), one of the most severe refractory allergic conjunctival diseases, have been described in several studies. [1][2][3] VKC involves severe allergic inflammation sufficient to cause the formation of proliferative conjunctival giant papillae, hyperemia, edema, swelling, mucous discharge and corneal damage. It has been reported that the infiltration of inflammatory cells such as mast cells, eosinophils, neutrophils, and T cells were detected in the papillae of VKC patients. [4][5][6][7][8] Therefore, in addition to immunoglobulin E (IgE)-mediated allergy induced by mast cells, a late phase reaction mediated by eosinophils and delayed-type allergy induced by T cells are thought to be involved in VKC induction.Fukushima et al. reported the inhibitory effect of CyA eye drops on eosinophil infiltration in a mouse allergic conjunctivitis model. 9) We have also reported that the instillation of CyA inhibited neutrophil infiltration into the conjunctiva in a delayed-type allergic conjunctivitis model in guinea pigs. 10)However, the efficacy of CyA eye drops in treating the symptoms in these allergic conjunctivitis models has not been previously reported. Therefore, to understand how CyA works in VKC therapy, we investigated the effects of CyA eye drops on ocular symptoms in late phase and delayed-type allergic conjunctivitis models in guinea pigs. Animals Five-week-old male guinea pigs (Hartley, Nippon SLC, Shizuoka, Japan) were housed under a 12-h light-12-h dark cycle (07:00-19:00 h), with room temperature maintained at 23Ϯ3°C and humidity at 50Ϯ20%. Food and water were given ad libitum. All experiments were performed in accordance with the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research and approved by the Santen Institutional Animal Care and Use Committee. MATERIALS AND METHODS ReagentsInduction of Late Phase Reaction in the Allergic Conjunctivitis Model Allergic conjunctivitis was induced using the method of Sengoku et al.,11) with some modification. OVA solution (40 mg/ml dissolved in saline) was emulsified with an equal volume of FCA. Then, 1 ml of the mixture was intraperitoneally injected into guinea pigs on days 0 and 7. Twenty-four days after the first immunization, 10 ml of 15% OVA solution was applied topically to the right eye to elicit an allergic reaction. Inhibitory Effects of Cyclosporine A Eye Drops on Symptoms in Late Phase and Delayed-Type Reactions in Allergic Conjunctivitis ModelsDaisuke SHII,* Shizu NAKAGAWA, Miwa YOSHIMI, Osamu KATSUTA, Tomoko ODA, and Masat...

show abstract

Section: Reagentsmentioning

confidence: 99%

“…Model Delayed-type allergic conjunctivitis was induced using the method of Sengoku et al, 11) with some modification. Guinea pigs were sensitized by injecting FCA (100 ml) into the footpad.…”

Section: Induction Of the Delayed-type Allergic Conjunctivitismentioning

confidence: 99%

Inhibitory Effects of Cyclosporine A Eye Drops on Symptoms in Late Phase and Delayed-Type Reactions in Allergic Conjunctivitis Models

Shii

Nakagawa

Yoshimi

et al. 2010

Biological & Pharmaceutical Bulletin

View full text Add to dashboard Cite

show abstract

“…Tacrolimus is an effective agent for the management of patients with AKC and VKC who are refractory to conventional medications, including topical cyclosporine [12][13][14][15][16][17][18]. In our study, topical tacrolimus achieved good results in the management of severe cyclosporine-resistant VKC.…”

Section: Discussionmentioning

confidence: 61%

“…The possibility of activation of herpes simplex dendritic keratitis by tacrolimus treatment requires further study. In a clinical study conducted by Sengoku et al [16] use of tacrolimus 0.1-1% eye drops achieved a dramatic improvement in the symptoms of patients with refractory VKC. In our study, 20 patients experienced initial mild conjunctival hyperemia (which subsides thereafter) for the first 3 days after initiation of treatment followed by relief of itching [TABLE 4].…”

Section: Discussionmentioning

confidence: 93%

“…Tacrolimus ointment is used widely for the treatment of atopic dermatitis. Topical tacrolimus (0.02-0.1%) has also been used to treat giant papillary conjunctivitis, atopic keratoconjunctivitis (AKC), and VKC [12][13][14][15][16][17][18] with good results. Furthermore, a tacrolimus 0.1% ophthalmic suspension has been used for the treatment of AKC and VKC with only 4 weeks of follow-up [18] The purpose of this study was to evaluate the long-term clinical outcomes of tacrolimus ointment as a treatment for refractory VKC.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Tacrolimus Ointment for Treatment of Vernal keratoconjunctivitis

Kumar¹,

Dwivedi²,

Verma³

et al. 2017

IOSR JDMS

View full text Add to dashboard Cite

Mast cell hyperplasia induced by multiple challenge with cedar pollen in sensitised guinea pigs

et al. 2005

View full text Add to dashboard Cite

show abstract

Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models

Abstract: FK506 eye drops inhibit late and delayed-type responses in animal models of ocular allergy.

Cited by 34 publications

References 27 publications

Inhibitory Effects of Cyclosporine A Eye Drops on Symptoms in Late Phase and Delayed-Type Reactions in Allergic Conjunctivitis Models

Inhibitory Effects of Cyclosporine A Eye Drops on Symptoms in Late Phase and Delayed-Type Reactions in Allergic Conjunctivitis Models

Tacrolimus Ointment for Treatment of Vernal keratoconjunctivitis

Mast cell hyperplasia induced by multiple challenge with cedar pollen in sensitised guinea pigs

Contact Info

Product

Resources

About